Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Investors Should Get Smarter

Mark Carhart was the guest of Columbia University’s Quantitative Finance program a few months ago. Carhart gave an hour long speech about quantitative finance and leaked some juicy details about Goldman Sachs, which we discussed some of it in a separate article. Mark Carhart was the poster child of quantitative finance, managing a $200 Billion portfolio at Goldman Sachs using quantitative investment strategies.

When calculating a portfolio manager’s alpha, Insider Monkey uses the four factor model developed by Mark Carhart as a student of Eugene Fama. It’s a beautiful model telling you not to give credit to portfolio managers who achieve their returns by consistently being long the market or consistently betting on small value stocks with price momentum. We showed that Warren Buffett didn’t generate any alpha between 2000 and 2009 by using Carhart’s methodology.

hedge funds vs. mutual funds

The reason was Warren Buffett consistently invests in value stocks. One can generate similar outcomes by simply investing in a portfolio of value stocks. A fund manager following value stocks can only generate alpha if he has some stock picking skills that can generate higher returns than a generic value strategy.

We noticed that it is not easy for several investors to understand the logic behind this methodology. So we always ask them this question: would you want to give a fund manager 2% of your capital and 20% of your returns every year because he is investing in value stocks with no particular stock picking ability? If your answer is yes, we urge you to contact us immediately because we can do this for you too.  The truth is you can do it too. You don’t even need to do it, there are several low cost mutual funds that do this for an annual fee of 50 basis points.

This was also one of the points Mark Carhart made in his speech.  Mark Carhart said an average long/short hedge fund has usually a 50% net market exposure. This means hedge fund investors are paying 1% of their assets and 10% of their profits (half of the usual amount because the fund has only 50 net exposure) for something Fidelity and Vanguard provide for 10 basis points per year. Investors shouldn’t pay astronomical hedge fund fees for simple beta. The second category is exotic beta. This is investing in small caps, value stocks, or momentum stocks. Fund managers can beat the market on the average by investing in these categories. You should expect your fund manager to invest in these categories but shouldn’t pay him the astronomical hedge fund fees for this.

Carhart says investors should analyze how their managers generate returns — alpha or beta. They should not be paying 2 and 20 for beta or exotic beta. Too many investors were attracted by high returns during the last bull market. Unfortunately most of those returns were coming from beta exposure. Investors should use quantitative methodologies to identify true alpha. Hedge fund managers don’t know or won’t tell you what their alpha is. They will try to convince investors that all the upside is true alpha. Unfortunately average hedge fund lost 15-20% in 2008 which tells us that they had enormous beta exposure. They still do.

If you don’t know how to calculate hedge funds’ alpha by using Carhart’s four-factor model, Insider Monkey can do it for you for free. All you need to do is to send us the monthly returns of the hedge fund you are considering and we will do the rest for you.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!